Clinical Trial Update: Endometriosis: Immunomodulation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial investigating immunomodulation for endometriosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Endometriosis | Phase 2, Phase 3 | Status: WITHDRAWN